Home › NDC Lookup › RxCUI directory › RxCUI 312004

250 ML nitroglycerin 0.2 MG/ML Injection — RxCUI 312004

Name: 250 ML nitroglycerin 0.2 MG/ML Injection (RxCUI 312004)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 312004 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312004

Official name250 ML nitroglycerin 0.2 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known as250 ML NTG 0.2 MG/ML Injection; nitroglycerin 50 MG in 250 ML Injection; 250 ML TNG 0.2 MG/ML Injection; nitroglycerin 200 MCG/ML per 250 ML Injection

FDA products mapped4

Package NDCs mapped4

Reported Medicaid activity (SDUD)8,485 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nitroglycerin Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It helps prevent angina, which is chest pain from coronary artery disease. It will not stop an attack that is already happening, because it doesn't work fast enough for that.
Wearing it around the clock can make it stop working, which is called tolerance. A break of about 10 to 12 hours each day helps prevent that. Follow the schedule your prescriber gi...
Why do I have to take the patch off every day?
Headache is the most common one, and it can be strong. Some people feel lightheaded, and the skin under the patch may be irritated. Call your doctor if you faint, if the headache i...

📖 Read our full Nitroglycerin Transdermal Patch guide →

🕸️ Concept Web — How 250 ML nitroglycerin 0.2 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 250 ML nitroglycerin 0.2 MG/ML Injection RxCUI 312004 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Nitroglycerin 4917 IN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Nitroglycerin Injection 1868493 SCDF
- Nitroglycerin Injectable Product 1159826 SCDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Nitroglycerin 0.2 MG/ML 316363 SCDC

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Nitroglycerin 0.2 MG/ML SCDC · 316363
Nitroglycerin Injection SCDF · 1868493
Nitroglycerin Injectable Product SCDG · 1159826

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 312004 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00338-1047-02	12 BOTTLE, GLASS in 1 BOX (0338-1047-02) / 250 mL in 1 BOTT...	Nitroglycerin In Dextrose	Baxter Healthcare Company	1989-12-29
00338-1049-02	12 BOTTLE, GLASS in 1 BOX (0338-1049-02) / 250 mL in 1 BOTT...	Nitroglycerin In Dextrose	Baxter Healthcare Company	1989-12-29
00338-1051-02	12 BOTTLE, GLASS in 1 BOX (0338-1051-02) / 250 mL in 1 BOTT...	Nitroglycerin In Dextrose	Baxter Healthcare Company	1989-12-29
51662-1332-01	250 mL in 1 BOTTLE, GLASS (51662-1332-1)	NITROGLYCERIN IN DEXTROSE	HF Acquisition Co LLC, DBA HealthFirst	2018-11-26

Observed labelers: Baxter Healthcare Company (3) · HF Acquisition Co LLC, DBA HealthFirst (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2305	Inj, nitroglycerin, 5 mg	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.